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Abstract: Background: Sulfated fucans show interesting effects in the treatment of ocular diseases
(e.g., age-related macular degeneration), depending on their chemical structure. Here, we compared
three purified sulfated fucans from Laminaria hyperborea (LH) regarding cell viability, oxidative
stress protection, and vascular endothelial growth factor (VEGF) secretion in ocular cells. Methods:
High-molecular-weight sulfated fucan (Mw = 1548.6 kDa, Fuc1) was extracted with warm water
and purified through ultrafiltration. Lower-molecular-weight samples (Mw = 499 kDa, Fuc2;
26.9 kDa, Fuc3) were obtained by mild acid hydrolysis of ultrapurified sulfated fucan and
analyzed (SEC-MALS (Size-exclusion chromatography-Multi-Angle Light Scattering), ICP-MS,
and GC). Concentrations between 1 and 100 µg/mL were tested. Cell viability was measured
after 24 h (uveal melanoma cell line (OMM-1), retinal pigment epithelium (RPE) cell line
ARPE-19, primary RPE cells) via MTT/MTS (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium
bromide/3-(4,5-Dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium)
assay. Oxidative stress protection was determined after 24 h (OMM-1, ARPE-19). VEGF secretion was
analyzed via ELISA after three days (ARPE-19, RPE). Results: Fuc2 and Fuc3 were antiproliferative
for OMM-1, but not for ARPE. Fuc1 protected OMM-1. VEGF secretion was lowered with all fucans
except Fuc3 in ARPE-19 and RPE. The results suggest a correlation between molecular weight
and biological activity, with efficiency increasing with size. Conclusion: The LH sulfated fucan
Fuc1 showed promising results regarding VEGF inhibition and protection, encouraging further
medical research.
Keywords: fucoidan; fucan; age-related macular degeneration; VEGF; oxidative stress; Laminaria
hyperborea; brown seaweed extracts; proliferation; molecular weight; retinal pigment epithelium
1. Introduction
Laminaria hyperborea (LH), commonly known as tangle or cuvie, belongs to the large brown
seaweed family of the Laminariaceae (alias kelp). It mainly grows in the northeast Atlantic Ocean,
especially around Scandinavia. LH, like all brown algal species, contains fucose-containing sulfated
polysaccharides (FCSP), commonly known as fucoidan, as a cell wall component. FCSP predominantly
based on sulfated L-fucose residues are defined as sulfated fucans [1]. FCSP are a very heterogeneous
group of polysaccharides with strong variations in sugar composition, degree of branching and
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sulfation, and molecular weight. Their structure depends on different aspects, like species, harvest
time, place, and extraction method [2]. This heterogeneity in structures also leads to a variety of
different biological activities. Sulfated fucans have been described as being able to reduce oxidative
stress and inflammation, as well as being capable of interfering with vascular endothelial growth factor
(VEGF) and blood lipids [3]. These properties render sulfated fucans very interesting for medical
purposes, especially for the treatment of age-related macular degeneration (AMD) [4]. AMD is the
main cause of blindness in the industrialized world and may cause an irreversible loss in central vision
in the elderly due to the degeneration of photoreceptors within the macula lutea. This may happen
in two ways: starting in the early phase with the deposition of drusen and an accumulation of lipid
peroxidation products (lipofuscin), it may progress to dry AMD, where retinal pigment epithelium
(RPE) degeneration is followed by a death of photoreceptors, leading to geographical atrophy of the
retina as a late stage [5,6]. In wet AMD, the major growth factor of blood vessels, VEGF, is abnormally
increased, leading to the growth of blood vessels under and into the retina. Followed by edema and
sometimes bleeding, it leads to a disruption of the retina [5]. The pathology of AMD is based on four
molecular mechanisms that increase the risk of this illness: inflammation, complement activation,
oxidative burden, and disturbed VEGF generation [5,7–9]. The only therapy possibility is repeated
anti-VEGF injections into the eyes of the patient [10], which slows down the pathology of wet AMD.
Because of their biological activities, FCSP are very interesting as possible new therapeutics for the
treatment of AMD [3]. We showed previously that commercial sulfated fucan from Fucus vesiculosus
reduces VEGF and the angiogenesis of RPE cells [4]. We also described the protective effects of
Saccharina latissima (SL) sulfated fucan for ARPE-19 cells against oxidative stress insult; this fucan also
lowered VEGF in ARPE-19 and RPE cells [11]. Other extracts from Fucus serratus, Fucus distichus subsp.
evanescens, and Laminaria digitata also inhibited VEGF secretion in ARPE-19 cells [11]. The chemical
structure and composition of sulfated fucan from LH has been previously described [12]. It was shown
that the biological activity of LH sulfated fucan is dependent on the molecular weight and the degree of
sulfation [12]. LH sulfated fucans with higher molecular weight and degree of sulfation were capable to
reduce coagulation and had anti-inflammatory effects [12]. Stefaniak-Vidarsson et al. (2017) described
the anti-proliferative effects of Laminaria sulfated fucans in activated human macrophages and showed
that these sulfated fucans triggered tumor necrosis factor-α and interleukins 6 and 10 [13]. However,
only few reports about the activity of LH sulfated fucans can be found in the literature. Because of
the described connected effects to molecular weight and to the high degree of sulfation, as well as the
different species-dependent structures and activities, we tested LH sulfated fucans additionally to the
other mentioned species to find the best sulfated fucans for further AMD-relevant research.
With this study we wanted to investigate whether these LH sulfated fucans display toxic effects
and whether they are capable of interfering with VEGF secretion and the oxidative burden in ocular
cells, with a view to making an important step further to new AMD treatment possibilities. For this
purpose, three pure sulfated fucans from LH were tested; these fucans differed only in their molecular
weight and were harvested at the same time, at the same place, with the same extraction method to
achieve high comparability.
2. Results
2.1. Structural Characterization of the Sulfated Fucans
Monosaccharide anion-exchange chromatography of Fuc1 revealed a sugar composition of 97.0%
± 0.1% fucose (retention time 3.134 min) and 3.0% ± 0.1% galactose (retention time 7.910 min). Neither
uronic acid residues nor glucose were detected.
Mass spectrometry of Fuc1 revealed a sulfite content (-SO3) of 29.44%, which converts into a
sulfation degree (DS) of approximately 1.7 sulfate groups per sugar residue (Table 1). Both (sugar
composition and DS) are in full agreement with the previously elucidated molecular structure [12].
An overlay of the Raman spectra from samples Fuc1, Fuc2, and Fuc3 showed no change in the relative
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intensities of the sulfate group vibrations (822.5 cm−1, 839.8 cm−1, 1065.3 cm−1, 1262.4 cm−1) and
methyl group vibrations (1340.9 cm−1, 1452.5 cm−1), indicating an equal ratio between the two groups
and thereby showing that no desulfation occurred during the mild acid hydrolysis.
SEC-MALS (Size-exclusion chromatography-Multi-Angle Light Scattering) analysis of Fuc1
revealed a very high molecular weight average of Mw = 1548 (± 4.1) kDa [14], resulting in an average
degree of polymerization (DPn) of 3512, with an approximated average monosaccharide unit weight
of 290 g/mol [12]. The molar mass was broadly distributed between 300 kDa and 7 MDa, displaying
coherent results throughout different injected volumes (50 µL and 100 µL, c = 1 g/L, see Figure 1).
The radius of gyration as the Z-average (Rz) was found to be 83.0 nm. The overall shape of the molecule
was determined through an rms conformation plot (rms radius [nm] versus M [g/mol], see Figure 2),
displaying a slope (b) of 0.66 and thus indicating an overall random coil shape of the molecule (sphere
b = 0.3; random coil b = 0.5; rigid rod b = 1) [15]. Considering the previously reported high degree
of branching of the molecule, while having obtained the same sugar composition and degree of
sulfation as shown in Kopplin et al. (2018) [12], the obtained shape of a random coil for an LH sulfated
fucan molecule 3 times bigger supports the previously suggested overall structure of a large, highly
flexible main chain with short side chains. Fuc2 and Fuc3 showed almost identical structural features,
only differing in their degree of polymerization.
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Figure 1. SEC-MALS (Size-exclusion chromatography-Multi-Angle Light Scattering) chromatogram of
the high-molecular-weight sulfated fucan (Fuc1) giving M [g/mol] versus V [mL]; 50 µL injection (pink),
100 µL injection (green). The molar mass is plotted as a dotted line, the refractive index is displayed as
an overlay.
Table 1. Data overview of the sulfated fucan samples used in this study. Degree of sulfation (DS), weight
average molar mass (Mw), number average molar mass (Mn), degree of polymerization (DP), Z-average
radius of gyration (Rz), refractive index increment (dn/dc), and slope of the RMS conformation plot
(b = rms versus M).
DS Mw [kDa] Mn [kDa] DPn Rz [nm] dn/dc b
Fuc1 1.7 1548 1021 3512 83.0 0.115 0.66
Fuc2 1.7 499 241 829 47.1 0.115 0.66
Fuc3 1.7 26.9 13.9 48 - 0.115 -
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2.2. Effects on Cell Viability
The uveal melanoma cell line OMM-1 was treated with the three LH sulfated fucans
for 24 h; after that, an MTS (3-(4,5-Dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-
(4-sulfophenyl)-2H-tetrazolium) assay was conducted. In all three cases a dose-dependent decrease in
cell viability starting with 1 µg/mL could be seen (Figure 3), but only Fuc2 and Fuc3 showed significant
effects: 50 and 100 µg/mL Fuc2 lowered cell viability to 83% ± 5% (p < 0.01) and 76% ± 6% (p < 0.001),
respectively. Quantities of 10, 50, and 100 µg/mL Fuc3 reduced cell viability even further to 87%
± 6%, 76% ± 5%, and 70% ± 9%, respectively. Fuc1, the sulfated fucan with the highest molecular
weight, showed no significant effects on cell viability but showed a tendency at 100 µg/mL, which is
not significant because of the higher variability.
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via MTS 
(3-(4,5-Dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium) assay 
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The human RPE cell line ARPE-19 was treated with the three LH sulfated fucans for 24 h and 
tested with a consecutive MTS assay. Only 50 µg/ml Fuc1 increased cell viability slightly (Figure 4). 
Figure 4. Cell viability was tested in retinal pigment epithelium (RPE) cell line ARPE-19 after 
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Figure 3. Cell viability was tested in uveal melanoma cell line OMM-1 after treatment with Laminaria
hyperborea (LH) sulfated fucans Fuc1 (a), Fuc2 (b), and Fuc3 (c) for 24 h. Cell viability was determined
via MTS (3-(4,5-Dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium)
assay and is shown as the mean and standard deviation in relation to a 100% control. Significance was
evaluated with ANOVA; * p < 0.05, ** p < 0.01, *** p < 0.001 compared to control (n = 4).
The human RPE cell line ARPE-19 was treated with the three LH sulfated fucans for 24 h and
tested with a consecutive MTS assay. Only 50 µg/mL Fuc1 increased cell viability slightly (Figure 4).
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Figure 4. Cell viability was tested in retinal pigment epithelium (RPE) cell line ARPE-19 after treatment
with LH sulfated fucans Fuc1 (a), Fuc2 (b), and Fuc3 (c) for 24 h. Cell viability was determined via MTS
assay and is shown as the mean and standard deviation in relation to a 100% control. Significance was
evaluated with ANOVA compared to the control (n = 4); + p < 0.05.
Primary porcine RPE cells were treated with the three LH sulfated fucans for 24 h and tested with
an MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) assay. The 10 µg/mL Fuc1
lowered viability slightly, but not to a biologically relevant degree (Figure 5). This paved the way for
extended incubation times to measure VEGF secretion after 72 h (see below).
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after 30 min incubation with the sulfated fucans. The oxidative agent was 1 mM H2O2, which reduced 
cell viability to under 60% in all cases. Viability was tested via MTS assay and is shown as the mean 
and standard deviation in relation to an untreated control (100%). The 10 µg/ml Fuc1 showed 
significant protective effects for the cell line. Significance was evaluated via ANOVA; */+ p < 0.05, 
versus 0 µg/ml sulfated fucan + 1 mM H2O2 (n = 4). 
RPE cells have the important role of protecting the cells of the retina against oxidative burden 
[7]. The RPE cell line ARPE19 was described to be rather resistant against hydrogen peroxide [17]. 
However, treatment with 0.5 mM tert-butyl hydroperoxide (TBHP) has a significant, consistent effect 
on the cell viability of ARPE-19 after 24 h, as previously shown [11]. 
Cell viability was effectively lowered to nearly 30% through oxidative stress with TBHP, but all 
LH sulfated fucans lowered the viability additionally to a lesser extent (Figure 7); the strongest effect 
Figure 5. Cell viability was tested in RPE cells after treatment with LH sulfated fucans
Fuc1 (a), Fuc2 (b), and Fuc3 (c) for 24 h. Cell viability was determined via MTT
(3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) assay and is shown as the mean and
standard deviation in relation to an untreated control (100%). Significance was evaluated with ANOVA
compared to the control (n = 3); * p < 0.05.
2.3. Oxidative Stress Protection
Oxidative stress protection by sulfated fucans from brown seaweed was already shown before for
OMM-1 with Fucus vesiculosus sulfated fucan from Sigma-Aldrich [16] and with sulfated fucans from
other seaweed, especially from SL, which was also protective for ARPE-19 [11]. So, these two cellular
model systems are suitable for testing LH sulfated fucans.
Starting with the melanoma cell line OMM-1, stress induction with 1 mM H2O2 led to decreased
cell viability of between 49% and 57% (Figure 6). The addition of 1–100 µg/mL Fuc2 showed no
protection. The same outcome was achieved via treatment with Fuc3, which significantly reduced
viability at 100 µg/mL (44% ± 9%, p < 0.05). Also, 50 µg/mL Fuc3 showed a slightly antiproliferative
effect which was not significant. Only the sulfated fucan with the highest molecular weight, Fuc1,
had significant protective effects at 10 µg/mL (65% ± 7%, p < 0.05).
RPE cells have the important role of protecting the cells of the retina against oxidative burden [7].
The RPE cell line ARPE19 was described to be rather resistant against hydrogen peroxide [17]. However,
treatment with 0.5 mM tert-butyl hydroperoxide (TBHP) has a significant, consistent effect on the cell
viability of ARPE-19 after 24 h, as previously shown [11].
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Figure 6. OMM-1 cell viability after treatment with Fuc1 (a), Fuc2 (b), and Fuc3 (c) and stress insult
after 30 min incubation with the sulfated fucans. The oxidative agent was 1 mM H2O2, which reduced
cell viability to under 60% in all cases. Viability was tested via MTS assay and is shown as the mean and
standard deviation in relation to an untreated control (100%). The 10 µg/mL Fuc1 showed significant
protective effects for the cell line. Significance was evaluated via ANOVA; */+ p < 0.05, versus 0 µg/mL
sulfated fucan + 1 mM H2O2 (n = 4).
Cell viability was effectively lowered to nearly 30% through oxidative stress with TBHP, but all
LH sulfated fucans lowered the viability additionally to a lesser extent (Figure 7); the strongest effect
was from 100 µg/mL of the Fuc3 sulfated fucan, which lowered the viability even further down to 18%
± 1% (p < 0.05).
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(100%). No sulfated fucan showed a significant protective effect for the RPE cell line. Significance was
evaluated with ANOVA; * p < 0.05, ** p < 0.01, *** p < 0.001, versus 0 µg/mL sulfated fucan + 0.5 mM
TBHP (n = 4).
2.4. VEGF Secretion
The effect of the three LH sulfated fucans on the secretion of VEGF was determined in the primary,
porcine RPE ells and t e human RPE cell line ARPE-19. ARPE-19 secreted nearly 4 imes l ss VEGF
co pared to the primary RPE cells (ARPE-19: 66 pg/h and RPE: 243 pg/h). The VEGF content secret d
into the supernatant of the cells w s collected for -19 over 24 h and for RPE over 4 h because of
the high r VEGF outcome. At this time point a medium xchange with added sulfated fucans was
performed. The VEGF content [pg/mL] was normalized to the cell viability (after 72 h sulfa ed fucan
treatment), giving the atio of VEGF/cell viability (in arbitrary units [arb. unit]). The cell viability of
both cell types with all sulfated fucans and ll test concentrations was essentially unaffected (data not
s own).
The secre ed VEGF as lowered by all tested sulfated fucans in ARPE-19 (Figure 8). Fuc3 reduced
VEGF to 0.84 ± 0.05 [arb. unit], p < 0.001, nd Fuc2 lower it to 0.66 ± 0.01 [arb. unit], p < 0.001,
at 100 µg/mL. The effect of Fuc2 and Fuc3 on VEGF was concentration dependent. This did not ap ly
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for Fuc1, the sulfated fucan with the highest molecular weight, which reduced VEGF to 0.48 ± 0.04
[arb. unit], p < 0.01, at 50 µg/mL and had the strongest effect of all sulfated fucans at this concentration.
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Figure 8. Vascular endothelial growth factor (VEGF) secretion of ARPE19 cells after incubation with
Fuc1 (a), Fuc2 (b), and Fuc3 (c). VEGF content was analyzed with ELISA and normalized to cell viability.
All LH extracts reduced VEGF content with 50 µg/mL Fuc1 as the most efficient. Significance was
evaluated with ANOVA; * p < 0.05, ** p < 0.01, *** p < 0.001 compared to the control (n = 4).
Due to the high amount of VEGF production in RPE cells, weaker effects could be expected,
but again VEGF was reduced by Fuc2 and Fuc1 (Figure 9). Fuc3, the smallest LH sulfated fucan,
seemed to increased VEGF secretion at 10 µg/mL (1.21 ± 0.04 [arb. unit]); however, this change was not
significant. Fuc2 reduced VEGF at 50 µg/mL to 0.64 ± 0.12 and at 100 µg/mL to 0.63 ± 0.10 [arb. unit],
p < 0.01, and Fuc1 reduced VEGF at 50 µg/mL to 0.30 ± 0.09 [arb. unit], p < 0.001. Once more, Fuc1 had
the highest efficiency and, similar to what was seen in ARPE-19, again showed the strongest effect at
50 µg/mL.
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3. Discussion
The different biological effects of sulfated fucans make them very interesting for medical research,
but each sulfated fucan should be exactly characterized because of the high heterogeneity concerning
these biological effects. Effects that are beneficial for the treatment of AMD were already described [2].
In this study we compared three purified sulfated fucans extracted from LH by Alginor ASA.
The chemical structure was previously characterized and differs among the three samples only by
the molecular weight average, which makes comparison in relation to the molecular weight possible.
The aim was to prescreen these extracts as to whether they are suitable for further AMD-related research.
To our knowledge, LH sulfated fucans had not been tested for this purpose before. Oxidative burden
and VEGF secretion are two important factors in the risk of developing AMD and were therefore the
main focus of this study. Because RPE cells are the target of the pathological mechanisms, they were
chosen as the cellular models. The melanoma cell line OMM-1 acted as a model for oxidative stress
protection as it is more susceptible to oxidative stress than the RPE cells.
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First, the LH sulfated fucans were tested for their effects on the viability of primary RPE cells
and the RPE cell line ARPE-19. In both cases there were no significant effects, which is in line with
earlier studies like that by Bittkau et al. 2019, which reported that sulfated fucans in general are
not antiproliferative for adherent cell lines [18]. However, this is dependent on the specific fucoidan
and model system. For example Banafa et al. described antiproliferative effects of Fucus vesiculosus
sulfated fucan in human breast cancer cells [19]. It was demonstrated that it arrests the cell cycle
at G1, has pro-apoptotic properties, and enhances ROS formation [19]. Fuc2 and Fuc3 showed cell
viability lowering effects in the melanoma cell line OMM-1, which could be desirable for possible use
in anticancer treatments. They both have a size below 500 kDa, so the effects could be connected to the
molecular weight and structure. Possibly, these sulfated fucans interfere with fibronectin, disturbing
the adherence of the tumor cell line [20]. Of note, the attachment of OMM-1 to well plates is rather
weak and the cells have no tight junctions, in contrast to the RPE and ARPE-19 cell lines. In addition,
OMM-1 cells were treated at subconfluence and the sulfated fucans could slow down the proliferation
of this cell line, whereas the RPE cells were already confluent.
Because oxidative burden is considered one of the main causes of the development of AMD [7],
the capability of the sulfated fucans to lower oxidative stress induced by TBHP or H2O2 was investigated.
In ARPE-19, no protective effects could be detected, and 100 µg/mL Fuc3 had a cumulative toxic
effect (also for OMM-1), which means that the smallest LH sulfated fucan enhanced the toxic effect
of TBHP and H2O2. The same outcome was achieved for the OMM-1 cell line, except for the biggest
sulfated fucan Fuc1, which was protective. These results are in contrast to those for the sulfated fucans
of Sargassum angustifolium, in which the antioxidant activity through the scavenging of radicals and
reducing power increased with decreasing size of the sulfated fucan (size range from 421 to 64 kDa) [21].
Because Fuc2 and Fuc3, which were also in that range, had no effect at all, and due to the absence
of polyphenols by virtue of the high purity, it could be assumed that Fuc1 had no scavenging effect
but rather interacted with the antioxidant defense system of the OMM-1 cell line. The RPE cells have
an already improved antioxidant defense system, controlled via Nrf-2 (transcription factor nuclear
factor erythroid 2-like 2), because of the high accumulation of oxygen radicals in the photoreceptors [7].
We already showed before that several sulfated fucans have protective effects in the OMM-1 cell line,
but rarely do they in the ARPE-19 cell line [11,16]. OMM-1 cells have decreased superoxide dismutase
activity [22], which could mean that the protective effects of ARPE-19 are concealed by already existing
antioxidant enzyme activity. That sulfated fucans can activate superoxide dismutase and Nrf-2 was
shown previously [23–26].
A further important factor, mainly for the development of wet AMD, is the secretion of VEGF,
which supports the angiogenesis of blood vessels in the eye. ARPE-19 cell lines and the primary RPE
cells were tested for their VEGF output after sulfated fucan treatment for three days. The secreted
VEGF was normalized to the cell viability. As shown before, primary RPE cells produce significantly
more VEGF compared to the cell line [11] (nearly 4 times more than ARPE-19); therefore, any significant
reduction of the growth factor in primary RPE cells is even more remarkable. All three LH sulfated
fucans decreased VEGF significantly at 50 and 100 µg/mL, with efficiency decreasing with smaller
size in the RPE and ARPE-19 cells. This reducing effect could be due to the direct binding of VEGF,
which inhibits the activation of the VEGF receptor. The negatively charged side chains of sulfated
fucans can interact with the positively charged residues of the VEGF molecule, which could explain
the interference in the binding between VEGF and its receptor [27]. This corresponds to findings in the
literature [28,29]. It could be assumed that bigger size of the sulfated fucan is more efficient in VEGF
inhibition. Also, direct interaction with the VEGF receptor (VEGF-R) [28] or the suppression of the
VEGF and VEGF receptor genes could be possible, as VEGF has been shown to be involved in its own
regulation [3,30–33]. Additional VEGF binding assays should be performed to determine the affinity
of the fucoidan to the growth factor, which should be considered for further studies with LH sulfated
fucans. Even more striking is the effect in the RPE cells, in which Fuc1 and Fuc2 also decreased VEGF
despite the higher secretion. For both cell types, 50 µg/mL Fuc1 had the strongest effect. Fuc3 showed a
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tendency to stimulate VEGF secretion in RPE cells; however, this was not significant and its biological
relevance is therefore uncertain. Nevertheless, it is of interest, as this small sulfated fucan may interact
with VEGF differently to its high-molecular-weight counterpart, possibly by binding to VEGF in a
VEGF-R-activating manner [34] The DS is also an important factor for the angiogenesis influencing
effect [29], but the DS for all three sulfated fucans was the same.
The monosaccharide analysis by anion-exchange chromatography revealed a polysaccharide
almost exclusively composed of fucose (97.0% fucose, 3.0% galactose). In addition, the sulfite content
(-SO3) of 29.44% (DS = 1.7) determined by ICP-MS is in strong agreement with data from the previously
elucidated LH sulfated fucan structure [12]. The obtained rms conformation plot slope (b) of 0.66
through SEC-MALS revealed a random coil shape for both Fuc1 and Fuc2, further supporting the
previously suggested long backbone structure (1→3 glycosidic linkages) with short side chains at 1→2
and 1→4 branching points. Therefore, the main difference between Fuc1, Fuc2, and Fuc3 was the
degree of polymerization, directly associating the effects on proliferation, oxidative stress protection,
and VEGF secretion with one structural property.
It has been shown that fucoidan, due to its high degree of sulfation, is able to bind to FGF (fibroblast
growth factor) receptors, similar to heparin, heparan sulfate, and sulfated alginate [35–37]. Further has
it been shown that the binding and inhibition of chemo- and cytokines, such as transforming growth
factor-β1 (TGF-β1), by sulfated fucans is size dependent. Even though the underlying mechanism is
not yet resolved, a similar binding preference could play a role [38].
Koyanagi et al. demonstrated that highly sulfated fucans are able to bind VEGF [29].
In addition, it has been found that polymers with conjugated inhibitors have a higher inhibitory
effect on tumor necrosis factor-α (TNF-α) if the inhibitors are attached to higher-molecular-weight
polymers; this is due to an increased diffusion time [39]. Since the binding of VEGF to highly sulfated
fucans has been proven, a similar effect of increased diffusion time could play a role.
FCSP are a diverse group of macromolecules with heterogeneous molecular structures. Still,
due to its almost exclusive fucose sugar composition and the full sulfation of almost every sugar unit,
LH sulfated fucan is rather homogeneous in nature, even when hydrolyzed to different molecular
weight averages. Hence, it can be speculated that biological effects on cells and the metabolism
are less likely caused by chemical reaction or direct receptor interactions only expressed by Fuc1
and not Fuc2 and Fuc3, but rather by physical and steric interactions such as stronger cell surface
adhesion or stronger entanglement with proteins (cadherins or cytokines) due to the higher average
molecular weight.
For further clarification, other FCSP with similar Mw but lower DS [14] should be included in future
studies, as well as high-molecular-weight hyaluronic acids, alginates, and sulfated alginates [40,41] to
better elucidate and distinguish the effects caused by molecular size, charge density, and degree of
sulfation and to determine if branching points and sugar composition play an additional role. Potential
FCSP–cytokine binding needs to be investigated to exclude potential masking of the determined VEGF
secretion. Finally, a chromatographic fractionation of high-molecular-weight LH sulfated fucan should
be applied to narrow down the molecular weight range and the polydispersity and to get access to
LH sulfated fucan fractions of even higher molecular weight, potentially amplifying the previously
expressed effects and directly relating them to specific molecular weight ranges.
From the results taken together, the sulfated fucan Fuc1 from LH with a molecular weight average
of 1548 kDa seems to be best candidate for further research concerning AMD-relevant mechanisms.
It did not lower the cell viability of primary RPE cells, and 50 µg/mL inhibited VEGF most efficiently.
High molecular weight appears to be desirable for VEGF inhibition. We tested several sulfated fucans
from different algal species previously; sulfated fucans from SL were also effective in oxidative stress
protection in the OMM-1 and ARPE-19 cell lines, and 10 µg/mL SL sulfated fucan inhibited VEGF in
ARPE-19 and RPE cells [11]. The molecular weight for this sulfated fucan was 1407 kDa (unpublished
data), so it is comparable to Fuc1, which also lowered VEGF significantly at 10 µg/mL in RPE and
ARPE-19. This renders SL and LH sulfated fucans as promising candidates for further AMD-related
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studies. Of note, the pure LH sulfated fucan in this study can be sustainably reproduced in high
amounts for further experiments in perfusion cultures or in vivo studies. Furthermore, because of
its protective effect in the sensitive OMM-1 cell line, it could be considered for future studies with
neuronal model systems concerning oxidative stress protection. For further research, tests concerning
inflammation, lipid metabolism, and complement systems would be of additional interest.
4. Material and Methods
4.1. Cell Culture
The uveal melanoma cell line OMM-1 [42] was provided by Dr. Sarah Coupland. RPMI 1640
(Merck, Darmstadt, Germany) was used for cultivation (with 10% fetal calf serum (Linaris GmbH,
Wertheim-Bettingen, Germany) and 1% penicillin/streptomycin (Merck, Darmstadt, Germany)).
The human RPE cell line ARPE-19 [43] was purchased from ATCC. The cultivation medium was
HyClone DMEM (GE Healthcare, München, Germany) with 1% penicillin/streptomycin, 1.2% HEPES,
1% non-essential amino acids (all from Merck, Darmstadt, Germany), and 10% fetal calf serum,
as previously described [11].
Primary porcine RPE cells were prepared as described before [30,44]. RPE cells were detached
from porcine eyes by trypsin incubation and cultivated in HyClone DMEM (GE Healthcare, München,
Germany) supplemented with penicillin/streptomycin (1%), HEPES (2.5%), non-essential amino acids
(1%) (all Merck, Darmstadt, Germany), and 10% fetal calf serum.
ARPE-19 and RPE were treated at confluence, and OMM-1 cells were treated at subconfluence.
4.2. Sulfated Fucan
Extraction: Freshly frozen LH was thawed, blended into small particles (≤ 3 mm), and kept in
90 ◦C H2O for 6 h. The solution was filtered (20–25 µm particle retention) using a vacuum pump;
CaCl2 was added to the filtrate and it was filtrated again (5 µm particle retention). The newly obtained
filtrate was purified through ultrafiltration (300 kDa MWCO) and lyophilized.
Hydrolyzation: Lower-molecular-weight samples were obtained by mild acid hydrolysis of the
ultrapurified sulfated fucan at pH = 3.0, 70 ◦C, and 5 min for Fuc2 and 35 min for Fuc3. The hydrolysates
were cooled in ice water, dialyzed again with distilled water for 3 h (12 kDa MWCO), and lyophilized.
The purified and dried LH sulfated fucans Fuc1, Fuc2, and Fuc3 were dissolved in 5 mg/mL
Ampuwa bidest (Fresenius, Schweinfurt, Germany). Before testing, the extracts were filtered with
0.2 µm Sarstedt filters (Nümbrecht, Germany) and further diluted in adequate medium to the
concentrations mentioned in 4.6, 4.7, 4.8 and 4.9.
4.3. Monosaccharide Analysis
The sulfated fucan samples were hydrolyzed using 3 mol/L trifluoroacetic acid (TFA) at 95 ◦C
for 12 h. The hydrolyzed monosaccharides were fractionated and analyzed through ion-exchange
chromatography equipped with a CarboPac PA20 (Thermo Fisher Scientific Inc., Waltham, MA,
USA) column.
4.4. Sulfate Content
The sulfate content of the ultrapurified sulfated fucan Fuc1 was externally analyzed using an
Agilent 7500 Series quadrupole ICP-MS. The sulfate content of the hydrolyzed sulfated fucans was
analyzed by Raman spectroscopy as previously described [12]. Raman spectra were recorded at room
temperature using a Horiba Jobin–Yvon LabRAM HR system equipped with a Raman microscope
(HORIBA Ltd., Kyoto, Japan).
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4.5. Molecular Weight Determination
The molecular weight of the sulfated fucan was determined by size-exclusion chromatography
(SEC) in the form of HPLC equipped with online multiangle static light scattering (MALS).
The measurements were performed at ambient temperature using a Shodex LB-806 and a 2500
PWXL column as a separator. The measurement was executed with a Dawn HELEOS-8+ multiangle
laser light scattering photometer (Wyatt, Santa Barbara, CA, USA) (λ0 = 660 nm) and a subsequent
Optilab T-rEX differential refractometer. The mobile phase was 0.10 mol/L Na2HPO4 (pH = 7), and the
flow rate was 0.2 mL/min. The injection volumes were 50 µL and 100 µL, with 1 g/mL. The data were
obtained and processed using Astra (v. 7) software (Wyatt, Santa Barbara, CA, USA).
4.6. Oxidative Stress
To induce oxidative-stress-related cell death, OMM-1 cells were treated with 1 mM H2O2 and
ARPE-19 cells were treated with 500 µM TBHP as previously established [11,16] to reduce cell viability
to nearly 50% (tested via MTS assay, see below). Before insult with the oxidative agents, cells were
incubated with 1, 10, 50, and 100 µg/mL LH extracts.
4.7. Methyl Thiazolyl Tetrazolium (MTT) Assay
The widely used MTT assay [45] was conducted as previously described [4,11] and was used
after taking supernatants for the VEGF ELISA (see below) and after 24 h sulfated fucan (1–100 µg/mL)
stimulation. The cells were incubated with 0.5 mg/mL MTT for 2 h and dissolved in DMSO. Measurement
was taken at 550 nm with an Elx800 (BioTek Instruments Inc., Bad Friedrichshall, Germany).
4.8. MTS Assay
The CellTiter 96® AQueous One Solution Cell Proliferation Assay from Promega Corporation
(Mannheim, Germany) was used to measure the cell viability after 24 h treatment with 1–100 µg/mL
LH extracts and in parallel to determine any protective effects after insult with oxidative stress.
The abovementioned media and supplements were used without phenol red. To each well, 20 µl MTS
was added, and the plates were incubated for 1 h.
4.9. VEGF ELISA
ARPE-19 and RPE supernatants were collected after treatment with LH extracts (1, 10, 50,
and 100 µg/mL) on Day 3 after stimulation [11]. Medium with sulfated fucan was exchanged 24 h
(ARPE-19) or 4 h (RPE) before collecting supernatants. Human VEGF DuoSet® ELISA was used for
ARPE-19, whereas the Human VEGF Quantikine® ELISA was used for RPE supernatants (both R&D
Systems, Wiesbaden, Germany). ELISAs were performed according to the manufacturer’s instructions.
Untreated cells and medium samples were tested as controls. To set the VEGF secretion in relation to
the cell viability, MTT assay was conducted after collection of the supernatants on Day 3.
4.10. Statistics
Experiments were independently repeated at least three times. Statistics were calculated in
Microsoft Excel (Excel 2010, Microsoft) and GraphPad PRISM 7 (GraphPad Software, Inc. 2017).
p values of <0.05, calculated via ANOVA, were considered significant. The diagram bars and lines
represent the mean and standard deviation, respectively.
5. Conclusions
The aim of this study was to investigate the effects of three pure sulfated fucans from
Laminaria hyperborea, which differed in their molecular size. The sulfated fucan origin and extraction
method were the same, and they differed only in the molecular weight average (Fuc1 > Fuc2 > Fuc3),
paving the way for comparable data. To test whether they are suitable for further testing for potential
Mar. Drugs 2019, 17, 548 12 of 14
treatment of, e.g., AMD, different tests regarding oxidative stress protection (MTS), cell viability
(MTT/MTS), and VEGF interference (VEGF ELISA) in ocular cells (OMM-1, ARPE-19, and RPE) were
performed. The cell viability of ARPE-19 and RPE was not influenced by up to three days of treatment;
this is important for further studies because it excludes toxic effects. Fuc2 and Fuc3 lowered the
cell viability of the melanoma cell line OMM-1 and should therefore be tested in further tumor cell
lines as to whether this is cell line specific or in general for tumor cells, which could pave the way
for anticancer studies. Fuc1, the biggest sulfated fucan, was the only one which showed protective
effects against oxidative stress (in OMM-1). Fuc3 reduced VEGF secretion in ARPE19 but stimulated
VEGF secretion in primary RPE cells. Conversely, Fuc2 and Fuc1 inhibited VEGF in ARPE-19 as well
as in RPE, with the strongest effect seen for 50 µg/mL Fuc1. Altogether, the results showed that the
biological activity of sulfated fucans is dependent on the molecular weight, and the desired effect for
the treatment of ocular diseases increases with the size of the sulfated fucan.
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